{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T10:05:06Z","timestamp":1795169106658,"version":"4.10.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T00:00:00Z","timestamp":1673913600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T00:00:00Z","timestamp":1673913600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["ZIC-MH002961"],"award-info":[{"award-number":["ZIC-MH002961"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurodevelop Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>For genetic conditions associated with neurodevelopmental disorder (GCAND), developmental domains such as motor ability, thinking and learning, social abilities, and communication are potential intervention targets. Performance on measures of developmental concepts can be expressed using several types of scores. Norm-referenced scores are intended for the diagnostic context, allowing for the identification of impairment relative to age-based expectations, and can exhibit dramatic floor effects when used in individuals with more significant limitations. Person ability scores, which are derived via Rasch analysis or item response theory, are available on many standardized tests and are intended to measure within-person change. However, they have not been used or evaluated as primary endpoints in GCAND clinical trials. In this study, we simulated a series of parallel-arm clinical trials under several chronological age and impairment conditions, to compare empirically the power and type I error rate of operationalizing test performance using ability scores rather than norm-referenced scores.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Using the Vineland Adaptive Behavior Scales as the example, we demonstrated an advantage in statistical power of ability scores over norm-referenced scores at extreme levels of impairment. This advantage was at least partially driven by floor effects in norm-referenced scores. For simulated conditions where impairment was less severe, ability scores outperformed norm-referenced scores, but they were more similar. The type I error rate closely approximated the nominal type I error rate of 5% for both scores.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The results of this simulation demonstrate a substantial power and interpretative advantage of ability scores over norm-referenced scores for studies of GCAND that will enroll participants with high levels of impairment. These results are expected to generalize to studies of developmental concepts, regardless of the etiology or specific test. However, the relative advantage of ability scores is expected to be even greater for tests with a higher floor than the Vineland.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s11689-022-09474-6","type":"journal-article","created":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T11:14:24Z","timestamp":1673954064000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Comparing ability and norm-referenced scores as clinical trial outcomes for neurodevelopmental disabilities: a simulation study"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6878-5199","authenticated-orcid":false,"given":"Cristan","family":"Farmer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Thurm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse D.","family":"Troy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron J.","family":"Kaat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,17]]},"reference":[{"issue":"10","key":"9474_CR1","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1038\/s41591-019-0581-5","volume":"25","author":"SJ Sanders","year":"2019","unstructured":"Sanders SJ, Sahin M, Hostyk J, Thurm A, Jacquemont S, Avillach P, et al. A framework for the investigation of rare genetic disorders in neuropsychiatry. Nat Med. 2019;25(10):1477\u201387.","journal-title":"Nat Med"},{"issue":"1","key":"9474_CR2","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1186\/s12864-021-08227-4","volume":"22","author":"N Maia","year":"2021","unstructured":"Maia N, Nabais S\u00e1 MJ, Melo-Pires M, de Brouwer APM, Jorge P. Intellectual disability genomics: current state, pitfalls and future challenges. BMC Genom. 2021;22(1):909.","journal-title":"BMC Genom"},{"key":"9474_CR3","doi-asserted-by":"crossref","unstructured":"Farmer C, Kaat AJ, Berry-Kravis E, Thurm A. Psychometric perspectives on developmental outcome and endpoint selection in treatment trials for genetic conditions associated with neurodevelopmental disorder. In: Esbensen A, Schworer E, editors. International Review of Research in Developmental Disabilities. Volume 62. Elsevier Inc. Academic Press; 2022. p 1\u201339.","DOI":"10.1016\/bs.irrdd.2022.05.001"},{"key":"9474_CR4","doi-asserted-by":"crossref","unstructured":"Aishworiya R, Valica T, Hagerman R, Restrepo B. An update on psychopharmacological treatment of autism spectrum disorder. Neurotherapeutics. 2022;14:1\u20135.","DOI":"10.1007\/s13311-022-01183-1"},{"issue":"3","key":"9474_CR5","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1007\/s13311-021-01082-x","volume":"18","author":"NA Copping","year":"2021","unstructured":"Copping NA, McTighe SM, Fink KD, Silverman JL. Emerging gene and small molecule therapies for the neurodevelopmental disorder angelman syndrome. Neurotherapeutics. 2021;18(3):1535\u201347.","journal-title":"Neurotherapeutics"},{"key":"9474_CR6","doi-asserted-by":"publisher","first-page":"695937","DOI":"10.3389\/fnmol.2021.695937","volume":"14","author":"TL Jensen","year":"2021","unstructured":"Jensen TL, G\u00f8tzsche CR, Woldbye DPD. Current and Future Prospects for Gene Therapy for Rare Genetic Diseases Affecting the Brain and Spinal Cord. Front Mole Neurosci. 2021;14:695937.","journal-title":"Front Mole Neurosci"},{"issue":"2","key":"9474_CR7","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1177\/1073191115580638","volume":"23","author":"HEM Oosterhuis","year":"2015","unstructured":"Oosterhuis HEM, van der Ark LA, Sijtsma K. Sample Size Requirements for Traditional and Regression-Based Norms. Assessment. 2015;23(2):191\u2013202.","journal-title":"Assessment."},{"issue":"1","key":"9474_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s11689-017-9193-x","volume":"9","author":"DB Budimirovic","year":"2017","unstructured":"Budimirovic DB, Berry-Kravis E, Erickson CA, Hall SS, Hessl D, Reiss AL, et al. Updated report on tools to measure outcomes of clinical trials in fragile X syndrome. J Neurodevelopment Disord. 2017;9(1):1\u201336.","journal-title":"J Neurodevelopment Disord"},{"issue":"6","key":"9474_CR9","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1352\/1944-7558-125.6.475","volume":"125","author":"C Farmer","year":"2020","unstructured":"Farmer C, Kaat AJ, Thurm A, Anselm I, Akshoomoff N, Bennett A, et al. Person ability scores as an alternative to norm-referenced scores as outcome measures in studies of neurodevelopmental disorders. Am J Intellect Dev Disabil. 2020;125(6):475\u201380.","journal-title":"Am J Intellect Dev Disabil."},{"issue":"1","key":"9474_CR10","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1866-1955-6-16","volume":"6","author":"SM Sansone","year":"2014","unstructured":"Sansone SM, Schneider A, Bickel E, Berry-Kravis E, Prescott C, Hessl D. Improving IQ measurement in intellectual disabilities using true deviation from population norms. J Neurodevelopment Disord. 2014;6(1):16.","journal-title":"J Neurodevelopment Disord."},{"key":"9474_CR11","doi-asserted-by":"crossref","unstructured":"Eisengart J, Daniel M, Adams H, Williams P, Kuca B, Shapiro E. Increasing precision in the measurement of change in pediatric neurodegenerative disease. Mole Genet Metab. 2022;137(1\u20132):201\u20139.","DOI":"10.1016\/j.ymgme.2022.09.001"},{"key":"9474_CR12","volume-title":"A common scale for the measurement of person ability and test item difficulty","author":"R Woodcock","year":"1971","unstructured":"Woodcock R, Dahl M. A common scale for the measurement of person ability and test item difficulty. Circle Pines: American Guidance Service, Inc.; 1971."},{"issue":"4","key":"9474_CR13","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/j.1751-9004.2009.00194.x","volume":"3","author":"MC Edwards","year":"2009","unstructured":"Edwards MC. An introduction to item response theory using the need for cognition scale. Soc Person Psychol Comp. 2009;3(4):507\u201329.","journal-title":"Soc Person Psychol Comp"},{"issue":"Spec Iss 1","key":"9474_CR14","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1017\/BrImp.2017.31","volume":"19","author":"J Kean","year":"2018","unstructured":"Kean J, Brodke DS, Biber J, Gross P. An introduction to Item Response Theory and Rasch Analysis of the Eating Assessment Tool (EAT-10). Brain Impair. 2018;19(Spec Iss 1):91\u2013102.","journal-title":"Brain Impair."},{"key":"9474_CR15","doi-asserted-by":"publisher","DOI":"10.1201\/9781315119144","volume-title":"Handbook of Item Response Theory: Three Volume","author":"WJ Van der Linden","year":"2018","unstructured":"Van der Linden WJ. Handbook of Item Response Theory: Three Volume. Set: CRC Press; 2018."},{"issue":"11","key":"9474_CR16","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1007\/s10803-013-1823-x","volume":"43","author":"ST Kover","year":"2013","unstructured":"Kover ST, McDuffie AS, Hagerman RJ, Abbeduto L. Receptive vocabulary in boys with autism spectrum disorder: cross-sectional developmental trajectories. J Autism Dev Disord. 2013;43(11):2696\u2013709.","journal-title":"J Autism Dev Disord."},{"issue":"2","key":"9474_CR17","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/jir.12313","volume":"61","author":"E Will","year":"2017","unstructured":"Will E, Fidler D, Daunhauer L, Gerlach-McDonald B. Executive function and academic achievement in primary\u2013grade students with Down syndrome. J Intellect Disabil Res. 2017;61(2):181\u201395.","journal-title":"J Intellect Disabil Res"},{"key":"9474_CR18","doi-asserted-by":"crossref","unstructured":"Sadhwani A, Wheeler A, Gwaltney A, Peters SU, Barbieri-Welge RL, Horowitz LT, et al. Developmental skills of individuals with Angelman syndrome assessed using the Bayley-III. J Autism Dev Disord. 2021;1-18.","DOI":"10.1007\/s10803-020-04861-1"},{"key":"9474_CR19","doi-asserted-by":"crossref","unstructured":"Kwok E, Feiner H, Grauzer J, Kaat AJ, Roberts MY. Measuring change during intervention using norm-referenced, standardized measures: a comparison of raw scores, standard scores, age equivalents, and growth scale values from the Preschool Language Scales-5. J Speech Lang Hear Res. 2022;65(11)4268\u201379.","DOI":"10.1044\/2022_JSLHR-22-00122"},{"issue":"7","key":"9474_CR20","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1080\/13854046.2017.1413211","volume":"32","author":"L Soorya","year":"2018","unstructured":"Soorya L, Leon J, Trelles MP, Thurm A. Framework for assessing individuals with rare genetic disorders associated with profound intellectual and multiple disabilities (PIMD): the example of Phelan McDermid Syndrome. Clin Neuropsychol. 2018;32(7):1226\u201355.","journal-title":"Clin Neuropsychol."},{"key":"9474_CR21","unstructured":"Food and Drug Administration. Rare Diseases: Natural History Studies for Drug Development. Silver Spring (MD): Department of Health and Human Services (US); 2019 March. Report No.: FDA-2019-D-0481."},{"issue":"7","key":"9474_CR22","doi-asserted-by":"publisher","first-page":"569","DOI":"10.3109\/0142159X.2012.670318","volume":"34","author":"I McManus","year":"2012","unstructured":"McManus I. The misinterpretation of the standard error of measurement in medical education: A primer on the problems, pitfalls and peculiarities of the three different standard errors of measurement. Med Teach. 2012;34(7):569\u201376.","journal-title":"Med Teach"},{"key":"9474_CR23","unstructured":"Wheeler A, Sadhwani A. Determining minimal clinically important differences for neurodevelopmental outcome measures in Angelman syndrome (Project 5R03HD105507) 2022 [Available from: https:\/\/reporter.nih.gov\/search\/BisxgeN8gUiwJ3w68Zs6xg\/project-details\/10396549."},{"key":"9474_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-7525-4-1","volume":"4","author":"FDA","year":"2006","unstructured":"FDA. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes. 2006;4:1\u201320.","journal-title":"Health Qual Life Outcomes."},{"key":"9474_CR25","unstructured":"Sparrow SS, Cicchetti DV, Saulnier CA. Vineland-3: Vineland adaptive behavior scales. NCS Pearson; 2016."},{"key":"9474_CR26","unstructured":"Daniel M, Vannier LC. Growth scale value (GSV): Theory, development, and applications (Growth Scale Value Technical Report Number 1). NCS Pearson; 2022."},{"key":"9474_CR27","volume-title":"R: A language and environment for statistical computing","author":"R Core Team","year":"2021","unstructured":"R Core Team. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2021."},{"issue":"19","key":"9474_CR28","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1002\/sim.1296","volume":"21","author":"SJ Pocock","year":"2002","unstructured":"Pocock SJ, Assmann SE, Enos LE, Kasten LE. Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practice and problems. Stat Med. 2002;21(19):2917\u201330.","journal-title":"Stat Med"},{"key":"9474_CR29","unstructured":"Sparrow SS, Cicchetti DV, Saulnier CA. Vineland Adaptive Behavior Scales, Third Edition Appendices B - E. NCS Pearson; 2016."}],"container-title":["Journal of Neurodevelopmental Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11689-022-09474-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s11689-022-09474-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11689-022-09474-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,21]],"date-time":"2023-01-21T03:37:28Z","timestamp":1674272248000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneurodevdisorders.biomedcentral.com\/articles\/10.1186\/s11689-022-09474-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,17]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["9474"],"URL":"https:\/\/doi.org\/10.1186\/s11689-022-09474-6","relation":{},"ISSN":["1866-1955"],"issn-type":[{"value":"1866-1955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,17]]},"assertion":[{"value":"24 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4"}}